PAR:VETO

Vetoquinol S.A. · PAR · Healthcare · EUR · FY for 2025

Figures on this page computed 2026-11-08 13:18 UTC

Last close

n/aEUR

Market data

17.9xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed
- Computed from the filing for 2025
14.4%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
10.9%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
9.8%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
0.03Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
EUR
- Computed from the filing for 2025
- Computed from the filing for 2025
1.0%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
EUR
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

All from 100

lens 2 of 9

Sales

150

2016-12-31 to 2025-12-31100 at the start150

Sales: 100.00 on 2016-12-31 to 150.05 on 2025-12-31, up 50%.

Profit

206

2016-12-31 to 2025-12-31100 at the start206

Profit: 100.00 on 2016-12-31 to 205.92 on 2025-12-31, up 106%.

Shares in issue

100

2016-12-31 to 2025-12-31100 at the start100

Shares in issue: 100.00 on 2016-12-31 to 100.23 on 2025-12-31, up 0%.

Sales is at 150, Profit is at 206, Shares in issue is at 100, against 100 in 2016.

Sales is at 150, Profit is at 206, Shares in issue is at 100, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100150
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Profit, where the first year is 100206
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR
Shares in issue, where the first year is 100100
Source
computed
Statement
income
Fiscal year
2025
Reported in
EUR